Recurrence of Hereditary Hemorrhagic Telangiectasia (HHT) After Liver Transplantation

Civil Hospices of Lyon

Status: Completed

Conditions: Liver Transplant; Hereditary Haemorrhagic Telangiectasia

Treatments: Other: Data collection from standard follow-up after liver transplant

Study type: Observational

Funder types: Other

Identifiers

NCT03942315

HHT

Details and patient eligibility

About

Liver transplantation (LT) has been proposed as a curative treatment in hereditary hemorrhagic telangiectasia (HHT) with severe hepatic involvement. The investigating team provides a long-term evaluation of graft status after LT for HHT with a focus on the risk of recurrence. The present study included all patients prospectively followed up after LT for HHT in the Lyon Liver Transplant Unit from 1993 to 2010 with a survival of more than 1 year.

Enrollment: 14 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hereditary Hemorrhagic Telangiectasia (HHT) patient who underwent liver transplant for HHT

Exclusion criteria

• Patient who died in the year following transplantation

Trial design

14 participants in 1 patient group

Liver transplant in Hereditary Hemorrhagic Telangiectasia

Description:

Hereditary Hemorrhagic Telangiectasia (HHT) patients who underwent a liver transplant in Lyon between 1993 and 2010, and who survived more than 1 year after transplantation.

Treatment:

Other: Data collection from standard follow-up after liver transplant